School of Medicine
Showing 21-40 of 163 Results
-
Laetitia Coassolo (Voilquin)
Senior Research Scientist - Basic Life, Pathology Sponsored Projects
BioI received my PharmD from the University of Strasbourg (France) in 2018. I completed my PhD in Oncology and Cell Biology in 2020 in Dr. Catherine Tomasetto's group in IGBMC (France) studying cell metabolism and cell signaling in breast cancer. I am now a postdoctal fellow in Dr. Katrin Svensson lab and I am highly interested in understanding the molecular mechanisms of non-classical hormones in metabolic diseases.
-
Maharshi Krishna Deb
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsI aim to gain insights of the molecular underpinnings that are critical for the specification of human germ cells as well as the episode of epigenetic reprogramming that they undergo which is critical for their development and thereby essential for perpetual propagation of human species. Under co-mentorship of Prof. Azim Surani and Dr. Shiv Grewal,I aim to learn these lessons from this immortal lineage of human germline to identify interventions against various pediatric as well as degenerative
-
Dorien Feyaerts
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsBiomedical scientist and immunologist with a strong background in fetal-maternal immunology that aims to conduct impactful translational research in women’s health to improve the health of mothers and their children.
-
Adina S. Fischer, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
On Leave from 10/10/2022 To 10/09/2024BioDr. Fischer’s research focuses on characterizing risk and resilience factors in depression. She has been awarded an NIH Career Development Award (K23) and Klingenstein Foundation Fellowship in Adolescent Depression to build her program of clinical and translational research at Stanford. Dr. Fischer's program of clinical care focused on the delivery and teaching of evidence-based clinical interventions that enhance resilience, with a focus on addressing the unique stressors encountered in academia and academic medicine that may contribute to risk and resilience in mood and anxiety disorders.
Dr. Fischer’s translational program of research focuses on:
(1) Improving our understanding of protective biomarkers of resilience to depression
(2) Characterizing the effects of cannabis on neurobiological function and depressive symptoms
(3) Developing neurobiologically-guided interventions for depressive disorders, particularly those that co-occur with cannabis and other substance use
Dr. Fischer earned her BSc at the Massachusetts Institute of Technology in Brain and Cognitive Sciences, where she conducted research in the Early Childhood Cognition Laboratory. She then completed the MD/PhD Program at Dartmouth, where she obtained her PhD in in Neuroscience. Dr. Fischer’s doctoral research focused on characterizing the acute effects of cannabis in patients with schizophrenia and co-occurring cannabis use disorder. She then completed the Stanford Psychiatry Residency Training Program as a member of the Research Track, and an NIH funded T-32 postdoctoral research fellowship within the Department of Psychiatry and Behavioral Sciences. -
Jenna Forsyth
Academic Program Professional, Medicine - Med/Infectious Diseases
BioJenna is a research scientist with the School of Medicine and affiliated with the King Center for Global Development, the Woods Institute for the Environment and the Doerr School of Sustainability. She completed her PhD with the Emmett Interdisciplinary Program in Environment and Resources and obtained her Master's in Civil and Environmental Engineering from the University of Washington. Her research brings together principles of environmental science, epidemiology, and behavior change. She develops and evaluates interventions to minimize exposures to contaminants and disease vectors in low-income countries. Her most recent research has focused on lead exposure in South Asia.
-
Connie Fung
Postdoctoral Scholar, Pathology
BioConnie received her B.S. in Microbiology, Immunology, and Molecular Genetics from UCLA, where she conducted research on how the eukaryotic parasite Toxoplasma gondii invades and replicates inside host cells in the lab of Dr. Peter Bradley. Subsequently, she obtained her Ph.D. in Microbiology & Immunology from Stanford University with Dr. Manuel Amieva. Her thesis research involved the use of high-resolution microscopy to study how the bacterium Helicobacter pylori establishes and maintains persistent colonization of the gastric epithelium. Connie joined Dr. Michael Howitt's lab as a postdoctoral research fellow in 2019 and is currently investigating how tuft cells, specialized taste-chemosensory cells, modulate epithelial cell function and mucosal immunity in response to intestinal parasites and commensals.
-
Elias Roth Gerrick
Postdoctoral Scholar, Pathology
BioEli received his B.S. in Microbiology and Immunology from U.C. Irvine in 2013, where he worked in the lab of Dr. Celia Goulding. He earned his Ph.D. from Harvard University in 2018 in the lab of Dr. Sarah Fortune, where he studied post-transcriptional regulation of gene expression in Mycobacterium tuberculosis. Eli joined the Howitt lab at Stanford in the summer of 2018, where he is studying the influence of protozoan members of the microbiome on intestinal immunity.
-
Ruth Margaret Gibson
Postdoctoral Scholar, Medicine
BioDr. Ruth M. Gibson is a Banting Postdoctoral Fellow at the Center for Innovation in Global Health, at Stanford University School of Medicine. Her research focuses on geopolitical coercion and global maternal child health. Prior to her return to academia, she spent a decade working in global health in countries such as Madagascar, Yemen, Saudi Arabia, and Ecuador.
-
Jessica Grembi
Postdoctoral Scholar, Infectious Diseases
BioEnvironmental enteric dysfunction (EED) affects 50-90% of children in low-income countries and is likely an important factor in child stunting as it impedes efficient nutrient uptake in the small intestine. EED is suspected to be the result of persistent exposure to enteric pathogens, although it has not been correlated with any specific pathogen. My research explores the interplay of gut microbiota, including enteric pathogens, and the host immune system with a focus on understanding EED so we can rationally design treatments and preventive measures.